has been cited by the following article(s):
|
[1]
|
Next-generation neurotherapeutics: nanotechnology, immunotherapy, and gene editing for neurodegenerative diseases
Neurodegenerative Disease Management,
2025
DOI:10.1080/17582024.2025.2520707
|
|
|
|
|
[2]
|
Veracity of In Silico Approach for Designing Rivastigmine-Polymer Nano Complexes for Intranasal Delivery: Prediction and In Vitro Validation
Journal of Pharmaceutical Innovation,
2024
DOI:10.1007/s12247-024-09892-0
|
|
|
|
|
[3]
|
Nexus of NFκB/VEGF/MMP9 signaling in diabetic retinopathy-linked dementia: Management by phenolic acid-enabled nanotherapeutics
Life Sciences,
2024
DOI:10.1016/j.lfs.2024.123123
|
|
|
|
|
[4]
|
Management of Brain Cancer and Neurodegenerative Disorders with Polymer-Based Nanoparticles as a Biocompatible Platform
Molecules,
2023
DOI:10.3390/molecules28020841
|
|
|
|
|
[5]
|
Combinatorial Assessment of Doxorubicin with Chlorogenic acid by in silico studies and development of its polymeric-nanoparticle against breast cancer
Materials Today: Proceedings,
2023
DOI:10.1016/j.matpr.2023.02.131
|
|
|
|
|
[6]
|
Phytopharmaceuticals and Herbal Drugs
2023
DOI:10.1016/B978-0-323-99125-4.00011-1
|
|
|
|
|
[7]
|
Block Co-polymeric Nanocarriers: Design, Concept, and Therapeutic Applications
2023
DOI:10.1007/978-981-99-6917-3_5
|
|
|
|
|
[8]
|
Dietary Plant Polyphenols as the Potential Drugs in Neurodegenerative Diseases: Current Evidence, Advances, and Opportunities
Oxidative Medicine and Cellular Longevity,
2022
DOI:10.1155/2022/5288698
|
|
|
|